Sapient Capital’s Novo Nordisk NVO Stock Holding History

Sapient Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$606K	Hold	12,651	–	–	0.01%	247
2026 Q1	$481K	Sell	12,651 -6,535	-34%	-$310K	0.01%	277
2025 Q4	$983K	Buy	19,186 +810	+4%	+$41.4K	0.01%	202
2025 Q3	$1.02M	Buy	18,376 +262	+1%	+$15.3K	0.02%	191
2025 Q2	$1.25M	Sell	18,114 -36,184	-67%	-$2.46M	0.02%	165
2025 Q1	$3.83M	Sell	54,298 -597,557	-92%	-$49.4M	0.08%	109
2024 Q4	$56.1M	Buy	651,855 +11,576	+2%	+$1.25M	1.07%	17
2024 Q3	$76.2M	Buy	640,279 +4,429	+0.7%	+$591K	1.53%	14
2024 Q2	$90.8M	Buy	635,850 +5,622	+0.9%	+$745K	1.89%	12
2024 Q1	$81.5M	Sell	630,228 -1,381	-0.2%	-$164K	1.81%	11
2023 Q4	$65.3M	Buy	+631,609	New	+$62.5M	1.69%	10

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Sapient Capital's NVO Position: Q2 2026 in Review

Sapient Capital held its Novo Nordisk (NVO) position steady in Q2 2026 at 12,651 shares worth $606K. The position accounts for 0.01% of the portfolio, ranked #247.

Sapient Capital first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $90.8M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Sapient Capital held 12,651 shares of Novo Nordisk worth $606K as of Q2 2026.
Sapient Capital left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.01% of Sapient Capital's portfolio in Q2 2026, its #247 holding.
Sapient Capital first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
Sapient Capital's Novo Nordisk position peaked at $90.8M in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.